Novartis oncology CEO makes hasty exit

Dec. 20, 2018

Just 11 months after taking on the role, Novartis oncology chief Liz Barrett said she is leaving to become chief executive of a U.S. biotech company.

Barrett will be replaced by Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company. Schaffert is a long-time Novartis exec.

Barrett cited challenges in moving her family to Basel, Novartis’s headquarters, as the reason for her departure.

Read the press statement